Literature DB >> 557509

Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures.

J P Atkinson, J M Michael, H Chaplin, C W Parker.   

Abstract

A quantitative rosette assay was employed in order to determine if through pharmacologic probes we could gain an insight into the nature of the interaction between C3b-coated particles and the macrophage C3b receptor. Rabbit alveolar macrophage monolayers were challenged with chromium-labeled, complement-coated (via cold agglutinin) human erythrocytes (HEC3b) and the per cent of bound counts determined in the distilled water lysate. With this assay system in which ingestion is negligible, the cytochalasins (A greater than E greater than D greater than B) produced the most marked inhibition of rosette formation compared to control treated monolayers. No agent examined produced consistent augmentation. Cytochalasin A at 10(-5), 10(-6), and 10(-7) M inhibited rosette formation by 77+/- 2, 44 +/- 4 and 15 +/- 7 (S.E.), per cent, respectively. Cytochalasin E was also markedly inhibitory, Cytochalasins B and D produced approximately 30% inhibition at 10(-5) M. The cytochalasin effect was not secondary to an interaction between these agents and complement-sensitized erythrocytes, although cytochalasin E was also able to reduce erythrocyte-bouund C3b reactivity. Cytochalasin A and E modulation of the macrophage C3b reactivity occurred within a few minutes and was only slightly reversible. Cytochalasins A and E could also disrupt performed rosettes but the effect was not as pronounced as when these agents were present before and/or during the actual adherence phenomenon. Vinblastine and colchicine (10(-5) and 10(-6) M) also produced significant inhibition of rosette formation, although the magnitude of the effect was less than that for cytochalasins A and E. Further characterization of the vinblastine and colchicine effect demonstrated that the inhibition was rapid, irreversible over a 60-min incubation, and not explained by an alteration in macrophage attachment or in HEC3b reactivity. Agents producing insignificant inhibition of rosette formation included the following: dibutyryl cAMP and cAMP agonists (PGE1, theophylline), 8-bromo cGMP and cGMP agonists (carbachol, asorbic acid), dimethylsulfoxide, heparin, ethanol, dextran sulfate, DEAE-dextran, and poly-L-lysine. The data suggest that cytochalasin, vinblastine and colchicine sensitive membrane structures, most likely microfilaments and microtubules, are important in the interaction of C3b-coated particles with the macrophage C3b receptor.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 557509

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Effects of surface-active agents on neutrophil receptors.

Authors:  L A Boxer; S B Richardson; R L Baehner
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

2.  Fc receptors of rat peritoneal macrophages: immunoglobulin class specificity and sensitivity to drugs affecting the microfilament or microtubule system.

Authors:  G A Medgyesi; G Fóris; B Dezsö; J Gergely; H Bazin
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

3.  Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages.

Authors:  T Schaffner; K Taylor; E J Bartucci; K Fischer-Dzoga; J H Beeson; S Glagov; R W Wissler
Journal:  Am J Pathol       Date:  1980-07       Impact factor: 4.307

4.  Cellular requirements for the formation of EA rosettes by human monocytes.

Authors:  J H Passwell; E Schneeberger; E Merler
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

5.  Chemotactic factor receptor modulation and cytoskeletal structures.

Authors:  I Spilberg; J Mehta
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

6.  Effect of angiotensin II on the Fc receptor activity of rat macrophages.

Authors:  B Dezsö; G Fóris
Journal:  Immunology       Date:  1981-02       Impact factor: 7.397

Review 7.  Cyclic AMP: master regulator of innate immune cell function.

Authors:  Carlos H Serezani; Megan N Ballinger; David M Aronoff; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2008-03-06       Impact factor: 6.914

8.  Enzymes altering the binding capacity of human blood eosinophils for IgG antibody-coated erythrocytes (EA).

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

9.  Release of arachidonic acid from human lymphocytes in response to mitogenic lectins.

Authors:  C W Parker; J P Kelly; S F Falkenhein; M G Huber
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

Review 10.  Preparations for Invasion: Modulation of Host Lung Immunity During Pulmonary Aspergillosis by Gliotoxin and Other Fungal Secondary Metabolites.

Authors:  Maykel Arias; Llipsy Santiago; Matxalen Vidal-García; Sergio Redrado; Pilar Lanuza; Laura Comas; M Pilar Domingo; Antonio Rezusta; Eva M Gálvez
Journal:  Front Immunol       Date:  2018-11-06       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.